N2-ethyldeoxyguanosine as a potential biomarker for assessing effects of alcohol consumption on DNA

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 11, 2008, Pages 3026-3032

  Balbo, Silvia ^a   Hashibe, Mia ^a   Gundy, Sarolta ^b   Brennan, Paul ^a   Canova, Cristina ^c   Simonato, Lorenzo ^c   Merletti, Franco ^d   Richiardi, Lorenzo ^d   Agudo, Antonio ^e   Castellsagué, Xavier ^e   Znaor, Ariana ^f   Talamini, Renato ^g   Bencko, Vladimir ^h   Holcátová, Ivana ^h   Wang, Mingyao ⁱ   Hecht, Stephen S ⁱ   Boffetta, Paolo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^f CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYANOBOROHYDRIDE SODIUM; DNA; GUANOSINE DERIVATIVE; N 2 ETHYLDEOXYGUANOSINE; SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG; DEOXYGUANOSINE; DRUG DERIVATIVE; N2 ETHYL 2' DEOXYGUANOSINE; N2-ETHYL-2'-DEOXYGUANOSINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA ISOLATION; DRINKING BEHAVIOR; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CASE CONTROL STUDY; CHEMICAL STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; SMOKING;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DNA ADDUCTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; SMOKING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 55849125829     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0117     Document Type: Article

References (21)

1. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006;7: 149-56.
2. IARC. Alcoholic beverage consumption and ethyl carbamate (urethane). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon (France): IARC. In press.
3. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. Review.
4. IARC. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon (France): IARC; 1999.
5. Wang M, McIntee EJ, Cheng G, Shi Y, Villalta PW, Hecht SS. Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 2000;13:1149-57.
6. Navasumrit P, Ward TH, O'Connor PJ, Nair J, Frank N, Bartsch H. Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. Mutat Res 2001;479:81-94.
7. Fang J, Vaca CE. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 1997; 18:627-32.
8. Matsuda T, Yabushita H, Kanaly RA, Shibutani S, Yokoyama A. Increased DNA damage in ALDH2-deficient alcoholics. Chem Res Toxicol 2006;19:1374-8.
9. Wang M, McIntee EJ, Cheng G, Shi Y, Villalta PW, Hecht SS. Reactions of 2,6-dimethyl-1,3-dioxane-4-ol (aldoxane) with deoxyguanosine and DNA. Chem Res Toxicol 2001;14:1025-32.
10. 2-ethyldeoxyguanosine. Chem Res Toxicol 2006;19: 319-24.
11. Chen L, Wang M, Villalta PW, et al. Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chem Res Toxicol 2007;20:108-13.
12. Willett W. Correction for the effects of measurement error. In: Willett W, editor. Nutritional epidemiology. New York: Oxford University Press; 1998. p. 302-20.
13. Gundy S, Székely G, Farkas G, Pulay A, Remenár É. Problems occurring in the application of cytogenetic biomarkers for alcoholics with and without malignant diseases. Magy Onkol 2008;52:153-61.
14. Burim RV, Canalle R, Satie Takahashi C, Crispim Tavares D, deLourdes Candolo Martinelli A, Tiem Sakamoto-Hojo E. Clastogenic effects of ethanol in chronic and abstinent alcoholics. Mutat Res 2004;560:187-98.
15. Székely G, Remenár É, Kásler M, Gundy S. Does bleomycin sensitivity assay express cancer phenotype? Mutagenesis 2003;18:53-63.
16. Székely G, Remenár É, Kásler M, Gundy S. Mutagen sensitivity of patients with cancer at different sites of the head and neck. Mutagenesis 2005;20:381-5.
17. WHO. Global status report on alcohol. Geneva:WHO; 2004. p. 22-44.
18. Swenberg J. Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies. In Buffler P, Rice J, Baan R, Bird M, Boffetta P, editors. Mechanisms of carcinogenesis. Lyon: IARC Sci Publ; 2004. p. 237-46.
19. Gubala W, Zuba D. Gender differences in the pharmacokinetics of ethanol in saliva and blood after oral ingestion. Pol J Pharmacol 2003; 55:639-44.
20. Brennan P, Boffetta P. Mechanistic considerations in the molecular epidemiology of head and neck cancer. In Buffler P, Rice J, Baan R, Bird M, Boffetta P, editors. Mechanisms of carcinogenesis. Lyon: IARC Sci Publ; 2004. p. 393-414.
21. Seeman JI, Dixon M, Haussmann HJ. Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker. Chem Res Toxicol 2002;15:1331-50.